10th Annual Neuroscience Innovation Forum

FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT

10th of January 2027|MARINES' MEMORIAL CLUB | SAN FRANCISCO | USA

Attendees:

1004 Venture Partners

153 Therapeutics, Inc.

3i Partners Fund II LLC

82VS

9vc

Ab Studio Inc.

AbbVie Ventures

Accequa

Acelot, Inc.

Actinogen Medical Ltd.

Age1 Capital Management, LLC

AlbionVC

Alignment Ventures, LLC

Alithia Life Sciences Pty Ltd

Alto Neuroscience Inc.

Alzheimer's Drug Discovery Foundation

Alzinova AB

Amplitude Ventures

Apollo Health Ventures

Aprecia Pharmaceuticals

Aqua Partners LLC

Aquillius Ventures

Argobio Studio

Ariadne Bio

Aspen Neuroscience, Inc.

AtaiBeckley

ATEM Capital

Balyasny Asset Management L.P.

Bayland Capital

Bayshore Global Management

Beacon Biosignals, Inc.

BERNINA BioInvest

BioAge Labs, Inc.

BioCentury Inc.

Biogen

BioInnovation Institute

Bioscience Equity Partners

BIOSTART Consulting GmbH

Biovision Ventures

Blackstone Group

Blue Matter Consulting

Bluezone Capital

Boehringer Ingelheim International GmbH

Bradley Woods & Co. Ltd.

BrainScope Company Inc.

BrainStorm Therapeutics, Inc.

Breslin AG

Brookline Capital Markets

CABHI Ventures

Canaccord Genuity LLC

Cantor Fitzgerald

CBT Advisors

Cervolve Inc.

CITICS CLSA Capital Partners HK Ltd

Claris Ventures SGR S.p.A.

Cognigenics, Inc.

Cognition Therapeutics, Inc.

Coho VC

Collage Venture Partners

Compass Pathways

Corundum Neuroscience Fund

Coya Therapeutics

DaCapo Brainscience, Inc.

DB Capital, LLC

DeBere Partners Limited

Debiopharm Innovation Fund SA

Decheng Capital LLC

Deerfield Management

Diadem Biotherapeutics, Inc.

Dolby Family Ventures

Eisai Innovation Inc.

Eli Lilly and Company

Eliraz Ventures

Emory Drug Development Fund

Endurance Bio Inc.

Enveric BioSciences, Inc.

F. Hoffmann - La Roche AG

F. Hoffmann-La Roche Ltd.

Ferghana Partners, Inc.

Fontaine Capital

Fraser Finance

Frazier Life Sciences

Galimedix Therapeutics, Inc.

Geneer Partners LLC

Generation Fund Life Sciences Fund I

Gilgamesh Pharmaceuticals

Global Asset Capital, LLC

Global BioAccess Fund

Gron Ventures

H. Lundbeck A/S

H.C. Wainwright & Co., LLC

Harness Therapeutics Ltd.

HEST Investments

Hummingbird Ventures

IAG Capital Partners

Innovestor Life Science Ltd.

Intermediate Capital Group PLC

Inveready Asset Management

IPF Partners

Ipsos Healthcare Advisory Service

J.P. Morgan

Jeito Capital

JLS Fund II LP

Johnson & Johnson Innovation – JJDC, Inc.

Johnston Associates, Inc.

Kaleida Capital

KeifeRx LLC

Kerna Ventures

Kidron Capital

Kinoxis Therapeutics Pty Ltd

L.E.K. Consulting

Labcorp

Ladenburg Thalmann & Co. Inc.

Lafana Life Sciences

Landmark Family Office

LivaNova

LMU Munich

Lumanity

Lumira Ventures

Luson Bioventures, LLC

M Ventures

Mass General Brigham Ventures

Mayo Clinic

MD Anderson Cancer Center

MedinCell S.A

Merck KGaA, Darmstadt, Germany

Merz Therapeutics GmbH

Mesa Verde Venture Partners

Mitsui Global Investment, Inc.

MRL Ventures Fund

MSQ Ventures

National Institutes of Health

Neuro-Innovators, Inc.

Neurvati Neurosciences, Inc.

New Harbor Venture Partners, LLC

NI Research Inc.

NIH/NIA

Nissan Chemical America Corporation

NodThera, Inc.

NovaRadar Bio Venture Corporation

Novatio Ventures

November International

Novo Holdings A/S

Novo Holdings US Inc.

NRx Pharmaceuticals, Inc.

o2h Ventures Ltd.

Oculis SA

OKG Capital LP

Ondura Biosciences

Oppenheimer & Co. Inc.

Osmind

Otsuka Pharmaceutical Co., Ltd.

Palo Alto Investors

Palo Santo Fund

Panakès Partners SGR SpA

Pangea Botanica Ltd

Parkinson's Research Ventures

Perceptive Advisors, LLC

PgRx Corporation

PJT Partners

Pritzker Neuropsychiatric Disorders Research Consortium

Psilera Inc.

Pullan Consulting

QurCan Therapeutics Inc.

Remiges Ventures, Inc.

Reunion Neuroscience, Inc.

Roth Capital Partners LLC

Roy Consulting

Saniona A/S

Satori Neuro Partners LP

Serenatis Bio Ltd.

Seventure Partners

Shanda Grab Ventures Limited

Sherpa Healthcare Partners

Shionogi & Co., Ltd.

Sifr Capital

Silicon Valley Venture Growth Partners

Sinaptica Therapeutics, Inc.

Sloan Ventures

Spark Biomedical, Inc.

Stand Up Therapeutics Inc.

Star Tree Ventures Ltd.

Strategic Swiss Partners GmbH

Stream Neuroscience Inc.

SV Health Investors

Synthesizer Drug Company, Inc.

Teva Pharmaceutical Industries Ltd.

The Global Emerging Markets Group (GEM)

The Michael J. Fox Foundation for Parkinson's Research

The Venture Collective

TheraVac Biologics

ThinkStern Ventures

Tonix Pharmaceuticals Holding Corp.

Transpacific Venture Capital Partners

UCB Pharma

UNEEG Medical A/S

V-Bio Ventures

V-Bio Ventures BV

Vandria SA

Venture Valuation

VersaPeutics Inc.

Vincere Biosciences Inc.

Vogel BioC

WBB Securities, LLC

Wellington Management

Wellington Partners

WRF Capital

XEIA Venture Partners

Yonjin Venture LLC

Yorkville Advisors Global, LP

Last updated: November 6, 2026

SACHS ASSOCIATES SWITZERLAND AG

Aeschenvorstadt 4
Basel | CH-4051
Switzerland

SACHS ASSOCIATES LTD.

3rd floor, 89-90 Paul Street
London | EC2A 4NE
United Kingdom
Privacy Policy

© COPYRIGHT 2026. ALL RIGHTS RESERVED.